Abstract:The most common mechanism of resistance to β-lactam antibiotics in Gram-negative bacteria is the production of β-lactamases that hydrolyze the drugs. Class A β-lactamases are serine active-site hydrolases that include the common TEM, CTX-M, and KPC enzymes. The TEM enzymes readily hydrolyze penicillins and older cephalosporins. Oxyimino-cephalosporins, such as cefotaxime and ceftazidime, however, are poor substrates for TEM-1 and were introduced, in part, to circumvent β-lactamase-mediated resistance. Nevertheless, the use of these antibiotics has lead to evolution of numerous variants of TEM with mutations that significantly increase the hydrolysis of the newer cephalosporins. The CTX-M enzymes emerged in the late 1980s and hydrolyze penicillins and older cephalosporins and derive their name from the ability to also hydrolyze cefotaxime. The CTX-M enzymes, however, do not efficiently hydrolyze ceftazidime. Variants of CTX-M enzymes, however, have evolved that exhibit increased hydrolysis of ceftazidime. Finally, the KPC enzyme emerged in the 1990s and is characterized by its broad specificity that includes penicillins, most cephalosporins, and carbapenems. The KPC enzyme, however, does not efficiently hydrolyze ceftazidime. As with the TEM and CTX-M enzymes, variants have recently evolved that extend the spectrum of KPC β-lactamase to include ceftazidime. This review discusses the structural and mechanistic basis for the expanded substrate specificity of each of these enzymes that result from natural mutations that confer oxyimino-cephalosporin resistance. For the TEM enzyme, extended-spectrum mutations act by establishing new interactions with the cephalosporin. These mutations increase the conformational heterogeneity of the active site to create sub-states that better accommodate the larger drugs. The mutations expanding the spectrum of CTX-M enzymes also affect the flexibility and conformation of the active site to accommodate ceftazidime. Although structural data are limited, extended-spectrum mutations in KPC may act by mediating new, direct interactions with substrate and/or altering conformations of the active site. In many cases, mutations that expand the substrate profile of these enzymes simultaneously decrease the thermodynamic stability. This leads to the emergence of additional global suppressor mutations that help correct the stability defects leading to increased protein expression and increased antibiotic resistance.

Five novel plasmid-determined beta-lactamases

Emergence of Novel Variants of Β-Lactamase Gene Blaadc and Outer Membrane Porin Gene Caro in Drug-Resistant Acinetobacter Baumannii

Detection of 22 beta-lactamase genes and enzyme activities in multi-drug resistant Acinetobacter baumannii

Whole-genome Sequence-Based Analysis of Klebsiella Pneumoniae JM45

The Resistance Genes of Extended- Spectrum Β- Lactamases in Enterobacter Cloacae

Genotypes of β-lactamases produced by Klebsiella pneumoniae

Nosocomial Spread of Multi-Resistant Klebsiella Pneumoniae Containing A Plasmid Encoding Multiple Beta-Lactamases

Characterization of a Novel Carbapenem-Hydrolysing Β-Lactamase OXA-1041 in Escherichia Coli.

The Expression of ESBLs Genes in Escherichia Coli Isolates Induced by Β-Lactam Antibiotics and Inhibited by Histidine Kinase Inhibitors

[Beta-lactamases in laboratory and their role in resistance Part I.: Evolution of bacterial resistance mediated by beta-lactamases]

Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance

Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases

The Molecular Epidemiology of Extended-Spectrum Β-Lactamases (ESBL) and Plasmid-Mediated AmpC Β-Lactamases ( P-Ampc ) Produced by the Clinical Strains of E. Coli and K.pneumoniae

[Study on the Genetic Structure and Transmission Mechanism of a Plasmid-Mediated AmpC Beta-Lactamase].

Landscape of Plasmids Encoding Β-Lactamases in Disinfection Residual Enterobacteriaceae from Wastewater Treatment Plants

OXA-427, a new plasmid-borne carbapenem-hydrolysing class D β-lactamase in Enterobacteriaceae

Systematic research to overcome newly emerged multidrug-resistant bacteria

Plasmid-mediated cephalosporinase among extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae]

Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases

The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases

Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae